Article
Cancer is present in 15% of men with 'normal' PSAs and DREs; 2% have high-grade disease
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
FDA news recap in urology for Q2 2025
Pearls & Perspectives: Disruptive Innovation in Urology, with Sijo J. Parekattil, MD
Enrollment begins in phase 2 trial of opaganib plus darolutamide in mCRPC
Pearls & Perspectives: Sexual Health in MSM, with Joshua R. Gonzalez, MD
Gedatolisib plus darolutamide shows encouraging activity in mCRPC
FDA updates in urology: June 2025
da Vinci 5 Surgical System approved in Europe
RX Review: Implementing mitomycin for LG-IR-NMIBC in clinical practice
RX Review: TURBT vs chemoablation for low-grade, intermediate-risk NMIBC